A proposal to nullify intellectual property regarding COVID-19 vaccines seems unlikely to affect Moderna's bottom line.Shares of Moderna (NASDAQ: MRNA) and its peers have been under pressure in response to a bomb the Biden administration's new trade envoy, Katherine Tai, dropped on America's ...

https://www.fool.com/investing/2021/05/08/4-reasons-to-hang-on-to-your-moderna-stock/?source=iedfolrf0000001

#fool